| Labatec Pharma SA - Ondansetron ODT Labatec 4 mg, comprimés orodispersibles | | 63263 | | 01 | | Ondansetron ODT Labatec 4 mg | | comprimés orodispersibles | | A04AA01 | | Ondansetron | | 27.08.2014 | | |
| | Composition | | ondansetronum 4 mg, mannitolum, sorbitolum 3.015-8.442 mg, crospovidonum, silica colloidalis anhydrica, cellulosum microcristallinum, crospovidonum, natrii stearylis fumaras corresp. natrium 0.1 mg, magnesii stearas, aromatica, aspartamum 0.88 mg pro compresso. | | Packungsbestandteile | | Melting tablets | | | | | Active Agent | Dose |
|---|
| Ondansetron | 4 mg |
| | BAG: Active Agent | Dose |
|---|
| Ondansetron | 4 mg |
| | | | Inactive agents | Dose |
|---|
| Aromatica | | | Aspartame | 0.88 mg | | Cellulosum Microcristallinum | | | Crospovidonum | | | Magnesii Stearas | | | Mannitol | | | Natrii Stearylis Fumaras | | | Pro Compresso | | | Silica Colloidalis Anhydrica | | | Sorbitol | 3.015-8.442 mg |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | 6 Tablet(s) | PR | PR | B | | Yes | | 002 | 10 Tablet(s) | 22.60 | 40.95 | B | SL | Yes |
|
|
